#USA #Raleigh #LabConnect #ClinicalTrials #ResearchTriangle

LabConnect Opens New Headquarters in Raleigh-Durham Area

In a significant move for the biopharmaceutical landscape, LabConnect, known for being one of the most agile partners in central laboratory solutions, has inaugurated its new corporate headquarters in Raleigh, North Carolina. This relocation not only underscores the company’s commitment to serving its clients better but also marks its strategic establishment in the Research Triangle area, recognized as a hub for Contract Research Organizations (CROs) and biotechnology initiatives.

The Research Triangle is renowned for its thriving life sciences ecosystem, supported by elite research institutions and a skilled labor force. This vibrant setting allowed LabConnect to enhance its collaborative potential with partners and customers, thereby fostering innovation particularly in the area of central lab services. The new head office will play a pivotal role in facilitating a wide array of complex clinical trials globally.

Wes Wheeler, LabConnect’s CEO, highlighted the strategic importance of its new headquarters, stating, "With this new Raleigh office, we are exactly where our customers are making some of their most important decisions about drug development. RDU has become one of the world’s most prominent centers for pharmaceutical innovation, and establishing a stronger corporate presence here allows us to partner even more closely with our clients."

LabConnect aims to leverage its North Carolina location to attract outstanding talent, which is vital for accelerating the development of new pharmaceuticals. The new Carolina corporate office adds to LabConnect’s global operational network of seven locations, which includes facilities across North America, Latin America, Europe, Australia, China, and South Korea. Each location works closely with regional partner labs, allowing LabConnect to synchronize its scientific, operational, and data capabilities effectively.

Moreover, LabConnect is poised for growth in Raleigh, with plans to expand its team focusing on commercial leadership, project management, scientific operations, technology, and data science. This investment represents the company's dedication to fostering a collaborative work environment that harnesses the strengths of the local market while simultaneously adhering to its global, asset-light operational model.

LabConnect’s innovative approach to laboratory services positions it as a technology-driven partner for the pharmaceutical and biotechnology sectors. Its decentralized operational model grants clients access to an extensive global testing menu, bolstered by advanced data management and sample tracking capabilities. With a focus on enhancing efficiency beyond traditional laboratory ownership, LabConnect aims to revolutionize the lab network for future therapeutic development.

For further information about LabConnect and its services, interested parties can follow the company on LinkedIn or visit its official website at www.labconnect.com.